{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:29Z","timestamp":1791296969807,"version":"4.1.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST104-2314-B-038-060"],"award-info":[{"award-number":["MOST104-2314-B-038-060"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12929-018-0430-8","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:44:05Z","timestamp":1522813445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Chang-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Song","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ho","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"issue":"12","key":"430_CR1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/aje\/kwi345","volume":"162","author":"LM Sun","year":"2005","unstructured":"Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Am J Epidemiol. 2005;162(12):1174\u20138.","journal-title":"Am J Epidemiol"},{"key":"430_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-6-1","volume":"6","author":"WC Cho","year":"2007","unstructured":"Cho WC. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer. 2007;6:1.","journal-title":"Mol Cancer"},{"issue":"1","key":"430_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/cncr.20768","volume":"103","author":"BB Ma","year":"2005","unstructured":"Ma BB, Chan AT. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer. 2005;103(1):22\u201331.","journal-title":"Cancer"},{"key":"430_CR4","first-page":"37","volume":"7","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ. Emerging treatment options for nasopharyngeal carcinoma. Drug Des Devel Ther. 2013;7:37\u201352.","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"430_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/CAD.0b013e328337160e","volume":"21","author":"F Caponigro","year":"2010","unstructured":"Caponigro F, Longo F, Ionna F, Perri F. Treatment approaches to nasopharyngeal carcinoma: a review. Anti-Cancer Drugs. 2010;21(5):471\u20137.","journal-title":"Anti-Cancer Drugs"},{"issue":"9","key":"430_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.oraloncology.2012.02.017","volume":"48","author":"AW Lee","year":"2012","unstructured":"Lee AW, Fee WE Jr, Ng WT, Chan LK. Nasopharyngeal carcinoma: salvage of local recurrence. Oral Oncol. 2012;48(9):768\u201374.","journal-title":"Oral Oncol"},{"issue":"1","key":"430_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12032-014-0392-y","volume":"32","author":"X Liu","year":"2015","unstructured":"Liu X, Ma D, Jing X, Wang B, Yang W, Qiu W. Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis. Med Oncol. 2015;32(1):392.","journal-title":"Med Oncol"},{"issue":"29","key":"430_CR8","doi-asserted-by":"publisher","first-page":"26946","DOI":"10.18632\/oncotarget.4521","volume":"6","author":"CY Chen","year":"2015","unstructured":"Chen CY, Lin YS, Chen CL, Chao PZ, Chiou JF, Kuo CC, Lee FP, Lin YF, Sung YH, Lin YT, et al. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma. Oncotarget. 2015;6(29):26946\u201359.","journal-title":"Oncotarget"},{"issue":"8","key":"430_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.18632\/oncotarget.1122","volume":"4","author":"NA Lokman","year":"2013","unstructured":"Lokman NA, Elder ASF, Ween MP, Pyragius CE, Hoffmann P, Oehler MK, Ricciardelli C. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget. 2013;4(8):1199\u2013211.","journal-title":"Oncotarget"},{"issue":"40","key":"430_CR10","doi-asserted-by":"publisher","first-page":"14346","DOI":"10.1523\/JNEUROSCI.3299-11.2011","volume":"31","author":"H Zhai","year":"2011","unstructured":"Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE. Annexin A2 promotes glioma cell invasion and tumor progression. J. Neurosci. Off. J. Soc. Neurosci. 2011;31(40):14346\u201360.","journal-title":"J. Neurosci. Off. J. Soc. Neurosci"},{"issue":"24","key":"430_CR11","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3748\/wjg.v19.i24.3792","volume":"19","author":"HJ Zhang","year":"2013","unstructured":"Zhang HJ, Yao DF, Yao M, Huang H, Wang L, Yan MJ, Yan XD, Gu X, Wu W, Lu SL. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells. World J. Gastroenterol. 2013;19(24):3792\u2013801.","journal-title":"World J. Gastroenterol"},{"key":"430_CR12","doi-asserted-by":"crossref","unstructured":"Zheng L, Foley K, Huang LQ, Leubner A, Mo GL, Olino K, Edil BH, Mizuma M, Sharma R, Le DT, et al. Tyrosine 23 phosphorylation-dependent cell-surface localization of Annexin A2 is required for invasion and metastases of pancreatic Cancer. PLoS One. 2011;6(4)","DOI":"10.1371\/journal.pone.0019390"},{"issue":"2","key":"430_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yexmp.2006.03.003","volume":"81","author":"MR Sharma","year":"2006","unstructured":"Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol. 2006;81(2):146\u201356.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"430_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mehy.2013.04.019","volume":"81","author":"GQ Zeng","year":"2013","unstructured":"Zeng GQ, Cheng AL, Tang J, Li GQ, Li MX, Qu JQ, Cao C, Liao L, Xiao ZQ. Annexin A1: a new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses. 2013;81(1):68\u201370.","journal-title":"Med Hypotheses"},{"issue":"6","key":"430_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/prca.200800164","volume":"3","author":"BHY Chow","year":"2009","unstructured":"Chow BHY, Chua DTT, Sham JST, Zhang MY, Chow LWC, Bi J, Ma NF, Xie D, Loo WTY, Fung JMW, et al. Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors. Proteom Clin Appl. 2009;3(6):654\u201362.","journal-title":"Proteom Clin Appl"},{"issue":"1","key":"430_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.18632\/oncotarget.2700","volume":"6","author":"PZ Chao","year":"2015","unstructured":"Chao PZ, Hsieh MS, Cheng CW, Hsu TJ, Lin YT, Lai CH, Liao CC, Chen WY, Leung TK, Lee FP, et al. Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN. Oncotarget. 2015;6(1):159\u201370.","journal-title":"Oncotarget"},{"key":"430_CR17","first-page":"308976","volume":"2014","author":"CY Wang","year":"2014","unstructured":"Wang CY, Lin CF. Annexin A2: its molecular regulation and cellular expression in cancer development. Dis Markers. 2014;2014:308976.","journal-title":"Dis Markers"},{"issue":"5","key":"430_CR18","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3892\/or.2015.3837","volume":"33","author":"XH Xu","year":"2015","unstructured":"Xu XH, Pan W, Kang LH, Feng H, Song YQ. Association of annexin A2 with cancer development (review). Oncol Rep. 2015;33(5):2121\u20138.","journal-title":"Oncol Rep"},{"issue":"11 Pt A","key":"430_CR19","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.bbagen.2017.08.024","volume":"1861","author":"AK Grindheim","year":"2017","unstructured":"Grindheim AK, Saraste J, Vedeler A. Protein phosphorylation and its role in the regulation of Annexin A2 function. Biochim Biophys Acta. 2017;1861(11 Pt A):2515\u201329.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"430_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00404-014-3598-5","volume":"292","author":"Y Deng","year":"2015","unstructured":"Deng Y, Chen C, Hua M, Xi Q, Liu R, Yang S, Liu J, Zhong J, Tang M, Lu S, et al. Annexin A2 plays a critical role in epithelial ovarian cancer. Arch Gynecol Obstet. 2015;292(1):175\u201382.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"430_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.urolonc.2014.02.009","volume":"32","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhao ZS, Ma YY, Wang HJ, Ma J, He XJ, Zhang DH. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma. Urol Oncol-Semin Ori. 2014;32(6):798\u2013805.","journal-title":"Urol Oncol-Semin Ori"},{"issue":"12","key":"430_CR22","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1007\/s13277-015-3678-6","volume":"36","author":"H Zhang","year":"2015","unstructured":"Zhang H, Yao M, Wu W, Qiu L, Sai W, Yang J, Zheng W, Huang J, Yao D. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. Tumour Biol.: J Int. Soc. Oncodev. Biol. Med. 2015;36(12):9373\u201383.","journal-title":"Tumour Biol.: J Int. Soc. Oncodev. Biol. Med"},{"key":"430_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2016.02.002","volume":"171","author":"NA Lokman","year":"2016","unstructured":"Lokman NA, Pyragius CE, Ruszkiewicz A, Oehler MK, Ricciardelli C. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Transl Res. 2016;171:83\u201395. e81-82","journal-title":"Transl Res"},{"issue":"8","key":"430_CR24","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/ijc.29213","volume":"136","author":"L Alonso-Alconada","year":"2015","unstructured":"Alonso-Alconada L, Santacana M, Garcia-Sanz P, Muinelo-Romay L, Colas E, Mirantes C, Monge M, Cueva J, Oliva E, Soslow RA, et al. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. Int J Cancer. 2015;136(8):1863\u201373.","journal-title":"Int J Cancer"},{"key":"430_CR25","doi-asserted-by":"crossref","unstructured":"El-Abd N, Fawzy A, Elbaz T, Hamdy S. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. Tumor Biol. 2016;37(1):211\u201316.","DOI":"10.1007\/s13277-015-3524-x"},{"issue":"9","key":"430_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4254\/wjh.v9.i9.469","volume":"9","author":"MK Shaker","year":"2017","unstructured":"Shaker MK, Fattah HIA, Sabbour GS, Montasser IF, Abdelhakam SM, El Hadidy E, Yousry R, El Dorry AK. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients. World J Hepatol. 2017;9(9):469\u201376.","journal-title":"World J Hepatol"},{"key":"430_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.biopha.2014.12.005","volume":"69","author":"F Tas","year":"2015","unstructured":"Tas F, Tilgen Yasasever C, Karabulut S, Tastekin D, Duranyildiz D. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables. Biomed Pharmacother. 2015;69:237\u201341.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"430_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/CBM-140455","volume":"15","author":"J Yang","year":"2015","unstructured":"Yang J, Yang F, Nie JQ, Zou XH, Tian HQ, Qin YE, Liu CQ. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer. Cancer Biomark. 2015;15(2):205\u201311.","journal-title":"Cancer Biomark"},{"issue":"5","key":"430_CR29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.joms.2016.10.032","volume":"75","author":"W Zhang","year":"2017","unstructured":"Zhang W, Gao C, Zhang S, Fang G. Serum Annexin A2 level is associated with diagnosis and prognosis in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg. 2017;75(5):1081\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"430_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/labinvest.2014.133","volume":"95","author":"C Kantara","year":"2015","unstructured":"Kantara C, O'Connell MR, Luthra G, Gajjar A, Sarkar S, Ullrich RL, Singh P. Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse\/metastasis. Lab Investig. 2015;95(1):100\u201312.","journal-title":"Lab Investig"},{"issue":"Pt 1","key":"430_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/jcs.101.1.25","volume":"101","author":"JK Vishwanatha","year":"1992","unstructured":"Vishwanatha JK, Jindal HK, Davis RG. The role of primer recognition proteins in DNA replication: association with nuclear matrix in HeLa cells. J Cell Sci. 1992;101(Pt 1):25\u201334.","journal-title":"J Cell Sci"},{"issue":"32","key":"430_CR32","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1038\/onc.2014.345","volume":"34","author":"T Kazami","year":"2015","unstructured":"Kazami T, Nie H, Satoh M, Kuga T, Matsushita K, Kawasaki N, Tomonaga T, Nomura F. Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage. Oncogene. 2015;34(32):4177\u201389.","journal-title":"Oncogene"},{"issue":"4","key":"430_CR33","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1172\/JCI59954","volume":"122","author":"SF Bakhoum","year":"2012","unstructured":"Bakhoum SF, Compton DA. Chromosomal instability and cancer: a complex relationship with therapeutic potential. J Clin Invest. 2012;122(4):1138\u201343.","journal-title":"J Clin Invest"},{"issue":"9","key":"430_CR34","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1073\/pnas.0308716101","volume":"101","author":"TL Wang","year":"2004","unstructured":"Wang TL, Diaz LA Jr, Romans K, Bardelli A, Saha S, Galizia G, Choti M, Donehower R, Parmigiani G, Shih Ie M, et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci U S A. 2004;101(9):3089\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"430_CR35","doi-asserted-by":"publisher","first-page":"14527","DOI":"10.1021\/bi00044a031","volume":"34","author":"I Hubaishy","year":"1995","unstructured":"Hubaishy I, Jones PG, Bjorge J, Bellagamba C, Fitzpatrick S, Fujita DJ, Waisman DM. Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry-Us. 1995;34(44):14527\u201334.","journal-title":"Biochemistry-Us"},{"issue":"6","key":"430_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrm1661","volume":"6","author":"V Gerke","year":"2005","unstructured":"Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol. 2005;6(6):449\u201361.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"430_CR37","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1128\/MCB.01247-07","volume":"28","author":"M de Graauw","year":"2008","unstructured":"de Graauw M, Tijdens I, Smeets MB, Hensbergen PJ, Deelder AM, van de Water B. Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin activation. Mol Cell Biol. 2008;28(3):1029\u201340.","journal-title":"Mol Cell Biol"},{"key":"430_CR38","doi-asserted-by":"crossref","unstructured":"Kpetemey M, Dasgupta S, Rajendiran S, Das S, Gibbs LD, Shetty P, Gryczynski Z, Vishwanatha JK: MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Mol Cancer. 2015;14:156","DOI":"10.1186\/s12943-015-0428-8"},{"issue":"5","key":"430_CR39","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.18632\/oncotarget.6723","volume":"7","author":"HY Cui","year":"2016","unstructured":"Cui HY, Wang SJ, Miao JY, Fu ZG, Feng F, Wu J, Yang XM, Chen ZN, Jiang JL. CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-beta-catenin-WAVE2 signaling. Oncotarget. 2016;7(5):5613\u201329.","journal-title":"Oncotarget"},{"issue":"5","key":"430_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"Pt 13","key":"430_CR41","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1242\/jcs.028415","volume":"121","author":"U Rescher","year":"2008","unstructured":"Rescher U, Ludwig C, Konietzko V, Kharitonenkov A, Gerke V. Tyrosine phosphorylation of annexin A2 regulates rho-mediated actin rearrangement and cell adhesion. J Cell Sci. 2008;121(Pt 13):2177\u201385.","journal-title":"J Cell Sci"},{"issue":"1","key":"430_CR42","doi-asserted-by":"publisher","first-page":"22 e11","DOI":"10.1016\/j.urolonc.2014.08.015","volume":"33","author":"SF Yang","year":"2015","unstructured":"Yang SF, Hsu HL, Chao TK, Hsiao CJ, Lin YF, Cheng CW. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance. Urol Oncol. 2015;33(1):22 e11\u201321.","journal-title":"Urol Oncol"},{"issue":"4","key":"430_CR43","first-page":"248","volume":"9","author":"YQ Wang","year":"2012","unstructured":"Wang YQ, Zhang F, Tian R, Ji W, Zhou Y, Sun XM, Liu Y, Wang ZY, Niu RF. Tyrosine 23 phosphorylation of Annexin A2 promotes proliferation, invasion, and Stat3 phosphorylation in the nucleus of human breast Cancer SK-BR-3 cells. Cancer Biol Med. 2012;9(4):248\u201353.","journal-title":"Cancer Biol Med"},{"issue":"39","key":"430_CR44","doi-asserted-by":"publisher","first-page":"32512","DOI":"10.1074\/jbc.M112.351957","volume":"287","author":"CY Wang","year":"2012","unstructured":"Wang CY, Chen CL, Tseng YL, Fang YT, Lin YS, Su WC, Chen CC, Chang KC, Wang YC, Lin CF. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem. 2012;287(39):32512\u201324.","journal-title":"J Biol Chem"},{"issue":"8","key":"430_CR45","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1074\/jbc.273.8.4790","volume":"273","author":"G Kassam","year":"1998","unstructured":"Kassam G, Choi KS, Ghuman J, Kang HM, Fitzpatrick SL, Zackson T, Zackson S, Toba M, Shinomiya A, Waisman DM. The role of annexin II tetramer in the activation of plasminogen. J Biol Chem. 1998;273(8):4790\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"430_CR46","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.3390\/ijms14036259","volume":"14","author":"A Bharadwaj","year":"2013","unstructured":"Bharadwaj A, Bydoun M, Holloway R, Waisman D. Annexin A2 heterotetramer: structure and function. Int J Mol Sci. 2013;14(3):6259\u2013305.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"430_CR47","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1515\/hsz-2016-0168","volume":"397","author":"T Grewal","year":"2016","unstructured":"Grewal T, Wason SJ, Enrich C, Rentero C. Annexins - insights from knockout mice. Biol Chem. 2016;397(10):1031\u201353.","journal-title":"Biol Chem"},{"issue":"25","key":"430_CR48","doi-asserted-by":"publisher","first-page":"23584","DOI":"10.1074\/jbc.M504325200","volume":"280","author":"M Kwon","year":"2005","unstructured":"Kwon M, Yoon CS, Jeong W, Rhee SG, Waisman DM. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin. J Biol Chem. 2005;280(25):23584\u201392.","journal-title":"J Biol Chem"},{"issue":"7","key":"430_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/09687688.2012.693210","volume":"29","author":"J Bandorowicz-Pikula","year":"2012","unstructured":"Bandorowicz-Pikula J, Wos M, Pikula S. Do annexins participate in lipid messenger mediated intracellular signaling? A question revisited. Mol Membr Biol. 2012;29(7):229\u201342.","journal-title":"Mol Membr Biol"},{"issue":"2","key":"430_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12253-011-9427-2","volume":"18","author":"YX Wang","year":"2012","unstructured":"Wang YX, Lv H, Li ZX, Li C, Wu XY. Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549. Pathol Oncol Res. 2012;18(2):183\u201390.","journal-title":"Pathol Oncol Res"},{"issue":"8","key":"430_CR51","doi-asserted-by":"publisher","first-page":"e67268","DOI":"10.1371\/journal.pone.0067268","volume":"8","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zhao P, Xu XL, Cai L, Song ZS, Cao DY, Tao KS, Zhou WP, Chen ZN, Dou KF. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells. PLoS One. 2013;8(8):e67268.","journal-title":"PLoS One"},{"issue":"3","key":"430_CR52","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1159\/000369745","volume":"35","author":"H Song","year":"2015","unstructured":"Song H, Pan D, Sun W, Gu C, Zhang Y, Zhao P, Qi Z, Zhao S. SiRNA directed against annexin II receptor inhibits angiogenesis via suppressing MMP2 and MMP9 expression. Cell Physiol Biochem. 2015;35(3):875\u201384.","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"430_CR53","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755\u201368.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"430_CR54","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1111\/febs.13023","volume":"281","author":"S Colak","year":"2014","unstructured":"Colak S, Medema JP. Cancer stem cells--important players in tumor therapy resistance. FEBS J. 2014;281(21):4779\u201391.","journal-title":"FEBS J"},{"key":"430_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2014.06.004","volume":"31","author":"M Cojoc","year":"2015","unstructured":"Cojoc M, Mabert K, Muders MH, Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol. 2015;31:16\u201327.","journal-title":"Semin Cancer Biol"},{"key":"430_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2013.08.001","volume":"39","author":"M Mimeault","year":"2014","unstructured":"Mimeault M, Batra SK. Altered gene products involved in the malignant reprogramming of cancer stem\/progenitor cells and multitargeted therapies. Mol Asp Med. 2014;39:3\u201332.","journal-title":"Mol Asp Med"},{"issue":"9","key":"430_CR57","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.18632\/oncotarget.3128","volume":"6","author":"J Qin","year":"2015","unstructured":"Qin J, Ji J, Deng R, Tang J, Yang F, Feng GK, Chen WD, Wu XQ, Qian XJ, Ding K, et al. DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2. Oncotarget. 2015;6(9):6944\u201358.","journal-title":"Oncotarget"},{"issue":"4","key":"430_CR58","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/or.2015.3752","volume":"33","author":"QW Zhao","year":"2015","unstructured":"Zhao QW, Zhou YW, Li WX, Kang B, Zhang XQ, Yang Y, Cheng J, Yin SY, Tong Y, He JQ, et al. Aktmediated phosphorylation of Oct4 is associated with the proliferation of stemlike cancer cells. Oncol Rep. 2015;33(4):1621\u20139.","journal-title":"Oncol Rep"},{"issue":"3","key":"430_CR59","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","volume":"4","author":"AM Bleau","year":"2009","unstructured":"Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC. PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 2009;4(3):226\u201335.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"430_CR60","doi-asserted-by":"publisher","first-page":"950","DOI":"10.4161\/cbt.11.11.15531","volume":"11","author":"H Li","year":"2011","unstructured":"Li H, Gao Q, Guo L, Lu SH. The PTEN\/PI3K\/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biol Ther. 2011;11(11):950\u20138.","journal-title":"Cancer Biol Ther"},{"key":"430_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1476-4598-11-73","volume":"11","author":"S Singh","year":"2012","unstructured":"Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, Altiok S, Chellappan SP. EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer. 2012;11:73.","journal-title":"Mol Cancer"},{"issue":"6","key":"430_CR62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4149\/neo_2014_078","volume":"61","author":"ZD Zhang","year":"2014","unstructured":"Zhang ZD, Li Y, Fan LQ, Zhao Q, Tan BB, Zhao XF. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway. Neoplasma. 2014;61(6):627\u201337.","journal-title":"Neoplasma"},{"issue":"2","key":"430_CR63","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bcp.2013.11.003","volume":"87","author":"F Zhang","year":"2014","unstructured":"Zhang F, Zhang H, Wang Z, Yu M, Tian R, Ji W, Yang Y, Niu R. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells. Biochem Pharmacol. 2014;87(2):292\u2013302.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"430_CR64","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1245\/s10434-008-0061-5","volume":"15","author":"S Takano","year":"2008","unstructured":"Takano S, Togawa A, Yoshitomi H, Shida T, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Tomonaga T, et al. Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy. Ann Surg Oncol. 2008;15(11):3157\u201368.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"430_CR65","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/mc.22126","volume":"54","author":"QZ Pan","year":"2015","unstructured":"Pan QZ, Pan K, Weng DS, Zhao JJ, Zhang XF, Wang DD, Lv L, Jiang SS, Zheng HX, Xia JC. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma. Mol Carcinog. 2015;54(8):598\u2013607.","journal-title":"Mol Carcinog"},{"issue":"1","key":"430_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1054\/bjoc.2000.1311","volume":"83","author":"EK Han","year":"2000","unstructured":"Han EK, Tahir SK, Cherian SP, Collins N, Ng SC. Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer. 2000;83(1):83\u20138.","journal-title":"Br J Cancer"},{"issue":"11","key":"430_CR67","doi-asserted-by":"publisher","first-page":"e80359","DOI":"10.1371\/journal.pone.0080359","volume":"8","author":"T Mogami","year":"2013","unstructured":"Mogami T, Yokota N, Asai-Sato M, Yamada R, Koizume S, Sakuma Y, Yoshihara M, Nakamura Y, Takano Y, Hirahara F, et al. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells. PLoS One. 2013;8(11):e80359.","journal-title":"PLoS One"},{"issue":"22 Pt 1","key":"430_CR68","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1158\/1078-0432.CCR-07-0569","volume":"13","author":"J Song","year":"2007","unstructured":"Song J, Shih Ie M, Salani R, Chan DW, Zhang Z, Annexin XI. Is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. Clin. Cancer Res. 2007;13(22 Pt 1):6842\u20139.","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"430_CR69","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1038\/sj.emboj.7601419","volume":"25","author":"A Lorusso","year":"2006","unstructured":"Lorusso A, Covino C, Priori G, Bachi A, Meldolesi J, Chieregatti E. Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis. EMBO J. 2006;25(23):5443\u201356.","journal-title":"EMBO J"},{"issue":"6","key":"430_CR70","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1600-0854.2007.00566.x","volume":"8","author":"E Cocucci","year":"2007","unstructured":"Cocucci E, Racchetti G, Podini P, Meldolesi J. Enlargeosome traffic: exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both. Traffic. 2007;8(6):742\u201357.","journal-title":"Traffic"},{"issue":"25","key":"430_CR71","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1016\/j.febslet.2007.09.026","volume":"581","author":"I Prada","year":"2007","unstructured":"Prada I, Cocucci E, Racchetti G, Meldolesi J. The Ca2+\u2212dependent exocytosis of enlargeosomes is greatly reinforced by genistein via a non-tyrosine kinase-dependent mechanism. FEBS Lett. 2007;581(25):4932\u20136.","journal-title":"FEBS Lett"},{"issue":"8","key":"430_CR72","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1248\/bpb.33.1261","volume":"33","author":"XG Gong","year":"2010","unstructured":"Gong XG, Lv YF, Li XQ, Xu FG, Ma QY. Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and Annexin A2 in pancreatic Cancer cells. Biol Pharm Bull. 2010;33(8):1261\u20137.","journal-title":"Biol Pharm Bull"},{"issue":"14","key":"430_CR73","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/onc.2010.566","volume":"30","author":"MM Chaturvedi","year":"2011","unstructured":"Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. NF-kappaB addiction and its role in cancer: 'one size does not fit all. Oncogene. 2011;30(14):1615\u201330.","journal-title":"Oncogene"},{"key":"430_CR74","doi-asserted-by":"publisher","first-page":"e1606","DOI":"10.1038\/cddis.2014.558","volume":"6","author":"H Jung","year":"2015","unstructured":"Jung H, Kim JS, Kim WK, Oh KJ, Kim JM, Lee HJ, Han BS, Kim DS, Seo YS, Lee SC, et al. Intracellular annexin A2 regulates NF-kappaB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer. Cell Death Dis. 2015;6:e1606.","journal-title":"Cell Death Dis"},{"key":"430_CR75","doi-asserted-by":"crossref","unstructured":"Madureira PA, Hill R, Lee PWK, Waisman DM. Genotoxic agents promote the nuclear accumulation of Annexin A2: role of Annexin A2 in mitigating DNA damage. PLoS One. 2012;7(11)","DOI":"10.1371\/journal.pone.0050591"},{"issue":"2","key":"430_CR76","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1242\/jcs.173195","volume":"129","author":"AK Grindheim","year":"2016","unstructured":"Grindheim AK, Hollas H, Raddum AM, Saraste J, Vedeler A. Reactive oxygen species exert opposite effects on Tyr23 phosphorylation of the nuclear and cortical pools of annexin A2. J Cell Sci. 2016;129(2):314\u201328.","journal-title":"J Cell Sci"},{"issue":"Pt 17","key":"430_CR77","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1242\/jcs.114.17.3155","volume":"114","author":"DA Eberhard","year":"2001","unstructured":"Eberhard DA, Karns LR, VandenBerg SR, Creutz CE. Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci. 2001;114(Pt 17):3155\u201366.","journal-title":"J Cell Sci"},{"key":"430_CR78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2091-4-10","volume":"4","author":"J Liu","year":"2003","unstructured":"Liu J, Rothermund CA, Ayala-Sanmartin J, Vishwanatha JK. Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II. BMC Biochem. 2003;4:10.","journal-title":"BMC Biochem"},{"issue":"10","key":"430_CR79","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1158\/1541-7786.MCR-10-0181","volume":"8","author":"R Kanagasabai","year":"2010","unstructured":"Kanagasabai R, Karthikeyan K, Vedam K, Qien W, Zhu Q, Ilangovan G. Hsp27 protects adenocarcinoma cells from UV-induced apoptosis by Akt and p21-dependent pathways of survival. Mol. Cancer Res. 2010;8(10):1399\u2013412.","journal-title":"Mol. Cancer Res"},{"issue":"2","key":"430_CR80","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1128\/CVI.00121-13","volume":"21","author":"VP Lutzky","year":"2014","unstructured":"Lutzky VP, Crooks P, Morrison L, Stevens N, Davis JE, Corban M, Hall D, Panizza B, Coman WB, Coman S, et al. Cytotoxic T cell adoptive immunotherapy as a treatment for nasopharyngeal carcinoma. Clin Vaccine Immunol. 2014;21(2):256\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"430_CR81","doi-asserted-by":"publisher","first-page":"607","DOI":"10.7150\/ijbs.7.607","volume":"7","author":"J Li","year":"2011","unstructured":"Li J, Chen QY, Mo H, Zhang YL, Huang ZF, Zeng YX. Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy. Int J Biol Sci. 2011;7(5):607\u201317.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"430_CR82","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.4161\/onci.21286","volume":"1","author":"C Smith","year":"2012","unstructured":"Smith C, Khanna R. A new approach for cellular immunotherapy of nasopharyngeal carcinoma. Oncoimmunology. 2012;1(8):1440\u20132.","journal-title":"Oncoimmunology"},{"issue":"5","key":"430_CR83","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/0008-5472.CAN-11-3399","volume":"72","author":"C Smith","year":"2012","unstructured":"Smith C, Tsang J, Beagley L, Chua D, Lee V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J, et al. Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. Cancer Res. 2012;72(5):1116\u201325.","journal-title":"Cancer Res"},{"issue":"4","key":"430_CR84","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0344-0338(11)80013-0","volume":"187","author":"A Giannini","year":"1991","unstructured":"Giannini A, Bianchi S, Messerini L, Gallo O, Gallina E, Asprella Libonati G, Olmi P, Zampi G. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. Pathol Res Pract. 1991;187(4):496\u2013502.","journal-title":"Pathol Res Pract"},{"issue":"8","key":"430_CR85","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1349-7006.1993.tb02064.x","volume":"84","author":"YS Zong","year":"1993","unstructured":"Zong YS, Zhang CQ, Zhang F, Ruan JB, Chen MY, Feng KT, Yu ZF. Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma. Jpn. J. Cancer Res.: Gann. 1993;84(8):900\u20135.","journal-title":"Jpn. J. Cancer Res.: Gann"},{"issue":"19","key":"430_CR86","first-page":"6478","volume":"63","author":"E Hartmann","year":"2003","unstructured":"Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, Giese T, Gires O, Endres S, Hartmann G. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 2003;63(19):6478\u201387.","journal-title":"Cancer Res"},{"issue":"1","key":"430_CR87","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12032-008-9093-8","volume":"26","author":"D Yufeng","year":"2009","unstructured":"Yufeng D, Guocheng Z, Dongliang X, Rong F, Yuhong C, Ruying L, Jingshi Z, Xuhong Z. Whole-tumor-antigen-pulsed dendritic cells elicit cytotoxic T-cell response against pediatric nasopharyngeal carcinoma in vitro. Med Oncol. 2009;26(1):78\u201385.","journal-title":"Med Oncol"},{"issue":"6673","key":"430_CR88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245\u201352.","journal-title":"Nature"},{"issue":"10","key":"430_CR89","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","volume":"146","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146(10):3444\u201351.","journal-title":"J Immunol"},{"issue":"10","key":"430_CR90","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","volume":"159","author":"K Steinbrink","year":"1997","unstructured":"Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997;159(10):4772\u201380.","journal-title":"J Immunol"},{"issue":"7","key":"430_CR91","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.4049\/jimmunol.165.7.3730","volume":"165","author":"EM Hiltbold","year":"2000","unstructured":"Hiltbold EM, Vlad AM, Ciborowski P, Watkins SC, Finn OJ. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J Immunol. 2000;165(7):3730\u201341.","journal-title":"J Immunol"},{"issue":"5","key":"430_CR92","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","volume":"100","author":"TBH Geijtenbeek","year":"2000","unstructured":"Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF, Middel J, Cornelissen ILMHA, Nottet HSLM, KewalRamani VN, Littman DR, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100(5):587\u201397.","journal-title":"Cell"},{"issue":"1","key":"430_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1074-7613(02)00259-5","volume":"16","author":"DS Kwon","year":"2002","unstructured":"Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity. 2002;16(1):135\u201344.","journal-title":"Immunity"},{"issue":"6","key":"430_CR94","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nri1845","volume":"6","author":"C Reis e Sousa","year":"2006","unstructured":"Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006;6(6):476\u201383.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"430_CR95","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.cellsig.2010.03.018","volume":"22","author":"U Svajger","year":"2010","unstructured":"Svajger U, Anderluh M, Jeras M, Obermajer N. C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal. 2010;22(10):1397\u2013405.","journal-title":"Cell Signal"},{"issue":"10","key":"430_CR96","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ni.2091","volume":"12","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol. 2011;12(10):959\u201365.","journal-title":"Nat Immunol"},{"issue":"1","key":"430_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1189\/jlb.0904484","volume":"77","author":"G Grutz","year":"2005","unstructured":"Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005;77(1):3\u201315.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"430_CR98","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ni.1778","volume":"10","author":"SI Gringhuis","year":"2009","unstructured":"Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TBH. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and helicobacter pylori. Nat Immunol. 2009;10(10):1081\u2013U1058.","journal-title":"Nat Immunol"},{"key":"430_CR99","doi-asserted-by":"crossref","unstructured":"den Dunnen J, Gringhuis SI, Geijtenbeek TBH: Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immun 2009, 58(7):1149-1157.","DOI":"10.1007\/s00262-008-0615-1"},{"issue":"11","key":"430_CR100","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1074\/jbc.M109.058370","volume":"285","author":"SC Hsu","year":"2010","unstructured":"Hsu SC, Chen CH, Tsai SH, Kawasaki H, Hung CH, Chu YT, Chang HW, Zhou YF, Fu JR, Plunkett B, et al. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells. J Biol Chem. 2010;285(11):7903\u201310.","journal-title":"J Biol Chem"},{"issue":"43","key":"430_CR101","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.1073\/pnas.0905815106","volume":"106","author":"J Chang","year":"2009","unstructured":"Chang J, Kunkel SL, Chang CH. Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci U S A. 2009;106(43):18327\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"430_CR102","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/MOT.0b013e32833b9bfb","volume":"15","author":"S Heidt","year":"2010","unstructured":"Heidt S, Segundo DS, Chadha R, Wood KJ. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr. Opin. Organ Transplant. 2010;15(4):456\u201361.","journal-title":"Curr. Opin. Organ Transplant"},{"issue":"6","key":"430_CR103","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","volume":"170","author":"DF Fiorentino","year":"1989","unstructured":"Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170(6):2081\u201395.","journal-title":"J Exp Med"},{"issue":"5","key":"430_CR104","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"R de Waal Malefyt","year":"1991","unstructured":"de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209\u201320.","journal-title":"J Exp Med"},{"issue":"3","key":"430_CR105","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.151.3.1224","volume":"151","author":"L Ding","year":"1993","unstructured":"Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993;151(3):1224\u201334.","journal-title":"J Immunol"},{"issue":"2","key":"430_CR106","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","volume":"157","author":"RT Gazzinelli","year":"1996","unstructured":"Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R, Muller W, Trinchieri G, Sher A. In the absence of endogenous IL-10, mice acutely infected with toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 1996;157(2):798\u2013805.","journal-title":"J Immunol"},{"key":"430_CR107","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683\u2013765.","journal-title":"Annu Rev Immunol"},{"key":"430_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2014.03.049","volume":"184","author":"T Andey","year":"2014","unstructured":"Andey T, Marepally S, Patel A, Jackson T, Sarkar S, O'Connell M, Reddy RC, Chellappan S, Singh P, Singh M. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model. J Control Release. 2014;184:67\u201378.","journal-title":"J Control Release"},{"issue":"1","key":"430_CR109","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2003.10.038","volume":"59","author":"DT Chua","year":"2004","unstructured":"Chua DT, Nicholls JM, Sham JS, Au GK. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59(1):11\u201320.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"430_CR110","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hed.10307","volume":"25","author":"BB Ma","year":"2003","unstructured":"Ma BB, Poon TC, To KF, Zee B, Mo FK, Chan CM, Ho S, Teo PM, Johnson PJ, Chan AT. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study. Head & neck. 2003;25(10):864\u201372.","journal-title":"Head & neck"},{"issue":"15","key":"430_CR111","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2005.02.147","volume":"23","author":"AT Chan","year":"2005","unstructured":"Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ, Hong RL, Whang-Peng J, Ma BB, To KF, et al. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2005;23(15):3568\u201376.","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol"},{"issue":"1","key":"430_CR112","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3892\/ol.2016.5406","volume":"13","author":"L Cui","year":"2017","unstructured":"Cui L, Song J, Wu L, Cheng L, Chen A, Wang Y, Huang Y, Huang L. Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells. Oncol Lett. 2017;13(1):377\u201383.","journal-title":"Oncol Lett"},{"issue":"9","key":"430_CR113","doi-asserted-by":"publisher","first-page":"e44299","DOI":"10.1371\/journal.pone.0044299","volume":"7","author":"PK Shetty","year":"2012","unstructured":"Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer. PLoS One. 2012;7(9):e44299.","journal-title":"PLoS One"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-018-0430-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-018-0430-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-018-0430-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:25:24Z","timestamp":1720203924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-018-0430-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1186\/s12929-018-0430-8","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"assertion":[{"value":"7 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"30"}}